(11C)SA4503,
1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride,
cutamesine,
SA 4503,
SA-4503,
SA4503,
165377-44-6,
1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride,
SA4503 dihydrochloride,
SA 4503 dihydrochloride,
Cutamesine dihydrochloride,
SA-4503 dihydrochloride,
UNII-B66RO93FXQ,
B66RO93FXQ,
SA 4503,
AK-33589,
1-(3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine 2HCl,
1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine Dihydrochloride,
SA 4503 (dihydrochloride),
XWOXAKBQEMQMFH-UHFFFAOYSA-N,
AGY94806 dihydrochloride,
SA4503 (dihydrochloride),
C23H34Cl2N2O2,
SA4503 2HCl,
SCHEMBL1299046,
CHEMBL3216524,
CTK8B8271,
DTXSID60433294,
BCP19110,
EX-A1190,
KS-00000H1H,
8394AA,
ANW-59863,
MFCD00939308,
AKOS016004527,
CD-1250,
CS-3288,
AS-43058,
AT-33501,
BC224713,
HY-13510,
AX8150709,
DB-018483,
LS-111470,
ST2403118,
TC-148608,
4CH-018975,
B5778,
FT-0764399,
A12984,
1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-piperazine dihydrochloride,
1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine--hydrogen chloride (1/2),
Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-, hydrochloride (1:2),
Cutamesine,
SA4503,
CID9954941,
1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride(SA 4503),
165377-43-5,